Archives cancer

by in
Entry Author Date Location
Green Park & Golf Brings Swedish Medtech “Cooling Cap” to Dallas 07/07/15 Texas
Texas Roundup: SXSW, SparkCognition, TMCx, & Austin’s Biotech Scene 06/30/15 Texas
Welcome To The Sharing Economy. Cancer Researchers Are Next. 06/23/15 National
Epizyme Shares Climb on New Data for Cancer Drug 06/22/15 Boston
West Coast Biotech Roundup: Avalanche, CytomX, BioMarin, Dubs & More 06/19/15 San Francisco
Cellectar Biosciences Appoints New CEO Amid Recent Turmoil 06/16/15 Wisconsin
Austin Biotech Aeglea BioTherapeutics Files for IPO for Cancer Therapies 06/16/15 Texas
Lycera’s End Game? $104M Celgene Deal Could Lead to Buyout 06/11/15 Detroit
XTuit Gets $22M From NEA, Polaris to Battle Cancer, Liver Disease 06/11/15 Boston
ASCO Roundup: Checkpoints, Pushback Against Prices, CAR-T & More 06/02/15 National
Fate of Life Sciences Fund Again in Limbo as Legislature Dithers 05/28/15 Seattle
Fate Therapeutics, Riding High on Juno Deal, Raising More Cash 05/19/15 San Diego
Ex-AstraZeneca Exec to Lead Surface’s “Next-Gen” Immuno-Oncology Plan 05/07/15 Boston
Funds Raised By ATI Startups Point to Growing Austin Biotech Scene 05/06/15 Texas
Austin Biotech Mirna Therapeutics Nabs Nearly $42M in Series D Funding 04/30/15 Texas
Blueprint Medicines Bags $147M in Upsized IPO 04/29/15 Boston
Dallas’ Health Wildcatters Second Class of Startups Raises $4.5M 04/28/15 Texas
TX Roundup: New Funding, an IPO, Rice Biz Plan winner, & More 04/27/15 Texas
Crossovers Arm Jounce With $56M For “Next Step” Immuno-Oncology 04/23/15 Boston
ImmuneXcite Enlists Body’s First Defender for Immune Attack on Cancer 04/21/15 Boston
Xbiotech’s $76M Offering Sets Course for Late-Stage Cancer Studies 04/15/15 Texas
Blend Therapeutics Taps Former Clinical Data Chief Fromkin As New CEO 04/13/15 Boston
Prenatal Screener Natera Grabs $55M, Considers Cancer Test 04/06/15 San Francisco
MD Anderson’s Chin Heads to UT to Lead Efforts to Fight Diabetes 04/02/15 Texas
Cancer Groups Tap The Crowd To Boost Clinical Trial Participation 04/01/15 Wisconsin
Novartis Bets $250M-Plus on Aduro’s Immuno-Oncology Work 03/30/15 San Francisco
Alexion Deal in Hand, Blueprint Readies IPO Pitch 03/23/15 Boston
Austin’s Aeglea Biotherapeutics Raises $44M for Cancer Drug 03/23/15 Texas
ImmunoGen Surges on $440M Takeda Deal For “Smart Bomb” Cancer Drugs 03/23/15 Boston
Pediatric Pitch Day Highlights Kids’ Health Innovation at SXSW 03/23/15 Texas
Page 1 of 59 next page »